MCI Welcomes Dr. Paul W. Hruz
MaterCare International is pleased to announce Dr. Paul W. Hruz presenting in our 2019 Rome Conference programme.
Dr. Hruz is Associate Professor of Pediatrics and Associate Professor of Cellular Biology and Physiology at Washington University in St. Louis. Dr. Hruz received his Bachelor's Degree in Chemistry from Marquette University in 1987. As a member of the Medical Scientist Training Program at the Medical College of Wisconsin, he received his PhD in Biochemistry in 1993 and M.D. Degree in 1994. He completed Residency training in Pediatrics at the University of Washington in Seattle and a Pediatric Endocrinology fellowship at Washington University. Dr. Hruz served at the Chief of the Division of Pediatric Endocrinology and Diabetes at Washington University from 2012-2017. He is a member of the University's Disorders of Sexual Development (DSD) Multidisciplinary Care Program. Dr. Hruz is board certified in Pediatrics and Pediatric Endocrinology. He has also received certification in Healthcare Ethics from the National Catholic Bioethics Center. He has authored over 60 peer-reviewed manuscripts, scientific reviews and book chapters.
His Rome Conference presentation is entitled "Medical Interventions for Gender Dysphoria: Separating Science and Ideology".
People who identify as a gender that does not correspond to their biological sex frequently experience psychological distress and serious adverse health outcomes. Over the past decade, increased recognition of this condition has led to the development of new medical approaches that include pubertal suppression and cross-sex hormonal therapy directed toward inducing physical changes corresponding to an individual’s identified gender. This is accompanied by efforts to mandate societal acceptance and accommodation of patient gender preferences. The risks, purported benefits, ethical concerns and societal implications of this new, and still controversial, treatment paradigm will be presented.